[{"target":4,"price":1.050,"returns":241,"ticker":"GNCA","note":"Genocea Biosciences (GNCA) look forward to reach average price target of $3.58 - Voice Of Analysts","to_char":"03/30/2019","q_eps":null,"a_eps":-0.330,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":18,"price":6.640,"returns":171,"ticker":"IDT","note":"Avg. Price Target Opinion: IDT Corporation (IDT) likely to achieve $18 in 52-week period - Voice Of Analysts","to_char":"03/30/2019","q_eps":null,"a_eps":0.140,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":12,"price":5.070,"returns":127,"ticker":"CRWN","note":"Raymond James Analysts Give Crown Capital Partners (TSE:CRWN) a C$11.50 Price Target - Fairfield Current","to_char":"03/30/2019","q_eps":null,"a_eps":0.000,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":3,"price":1.330,"returns":126,"ticker":"CTXR","note":"Price Target Summary: Citius Pharmaceuticals (CTXR) likely to touch $3 in 52-week period - Voice Of Analysts","to_char":"04/01/2019","q_eps":null,"a_eps":-1.010,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":11,"price":5.070,"returns":119,"ticker":"INAP","note":"Price Target Summary: Internap Corporation (INAP) likely to touch $11.18 in 52-week period - Voice Of Analysts","to_char":"03/30/2019","q_eps":null,"a_eps":-3.020,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null}]
